Chile approved emergency use of Russian vaccine Sputnik V

The vaccine already applied in 70 countries -Among them Argentina, Brazil and Mexico- in two separate doses of 21 days to people over 18 years and, according to clinical trials carried out, its effectiveness is 91.6%.

“All the studies show that the vaccine has a good safety profile and that most of the adverse events detected were mild, no unexpected adverse events were reported during clinical studies,” he added. Garcia indicated.

The Chilean government must now determine whether to include the Russian vaccine in the successful vaccination program against the virus through which 11.7 million people have already been vaccinated with two doses, corresponding to 77.36% of the target population (15.2 million out of a total of 19 million inhabitants).

To this end, Chile has acquired more than 27 million vaccines to date: 6,101,940 from Pfizer-BioNTech, 18,671,476 from Sinovac, 575,908 from CanSino and 1,713,600 from AstraZeneca. So far, Johnson & Johnson is not bought.

After 16 months of pandemic, Chile relaxed its health measures this week after registering the lowest number of infections since November.

According to the Chilean Ministry of Health, in the last 24 hours, 989 cases have been registered, totaling 1,602,854 infections, while there have been 42 deaths reaching a total of 34,611.